Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Professor Rose McGready

Professor Rose McGready

Podcast interview

Malaria in pregnancy

In pregnant women, severe malaria is responsible for high maternal mortality, and uncomplicated malaria results in in high morbidity. Careful documentation of treatments showed that, although not all drugs are available for pregnant women, early treatment can greatly increase the outcome of the pregnancy, and give that child a better chance at a productive life.

View podcast transcript

Social media

Rose McGready

Professor of Tropical Maternal and Child Health

Shoklo Malaria Research Unit

Rose McGready has worked for more than 28 years at the Shoklo Malaria Research Unit on the Thailand-Myanmar border. This research program is part of the Mahidol Oxford Tropical Medicine Research Unit and Rosie is one of the world leading experts in maternal malaria. Her research work has been translated into clinical practice and has resulted in dramatic improvements in the health of women in this marginalized population of South East Asia and beyond. Developing the team has been an essential and integral component of this process.

The mother and child health (MCH) team run a network of antenatal clinics and delivery facilities for the border population and have documented over 80,000 pregnancies in rural and resource limited settings, and their outcomes. This effort has resulted in a phenomenal contribution to the evidence base on the treatment of maternal malaria, the safety of the artemisinin derivatives in pregnancy including in the first trimester and the need to adapt the dosing of antimalarial drugs during gestation. This research has resulted in a paradigm shift on the effects of malaria on the women and newborns, demonstrating that single (even asymptomatic) infections with P. falciparum or P. vivax are detrimental. These infections are associated with miscarriage a difficult finding to determine in a rural and resource constrained setting.

The MCH team works collaboratively and has published widely on infectious  (HIV, Hep B, Syphilis, Scrub and Murine Typhus, Dengue, Toxoplasmosis, Soil-transmitted Helminths) and non-communicable disease; antenatal, obstetric and newborn care; nutrition and anaemia; and assessment of gestational age, newborn and infant development, and teaching and learning in resource limited settings.